The stock of SciSparc Ltd (SPRC) has seen a -24.09% decrease in the past week, with a 2.60% gain in the past month, and a 62.62% flourish in the past quarter. The volatility ratio for the week is 17.23%, and the volatility levels for the past 30 days are at 26.03% for SPRC. The simple moving average for the past 20 days is -37.78% for SPRC’s stock, with a -28.67% simple moving average for the past 200 days.
Is It Worth Investing in SciSparc Ltd (NASDAQ: SPRC) Right Now?
Additionally, the 36-month beta value for SPRC is 0.77.
The public float for SPRC is 10.36M and currently, short sellers hold a 2.83% ratio of that float. The average trading volume of SPRC on February 05, 2025 was 8.45M shares.
SPRC) stock’s latest price update
SciSparc Ltd (NASDAQ: SPRC)’s stock price has dropped by -8.89 in relation to previous closing price of 0.44. Nevertheless, the company has seen a loss of -24.09% in its stock price over the last five trading days. globenewswire.com reported 2025-02-04 that TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (FSE: CWY), a biotechnology company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems, Clearmind has announced the publication of a patent application in Mexico for the innovative combination of 3,4-Methylenedioxymethamphetamine (MDMA) with N-Acylethanolamines.
SPRC Trading at -5.33% from the 50-Day Moving Average
After a stumble in the market that brought SPRC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.06% of loss for the given period.
Volatility was left at 26.03%, however, over the last 30 days, the volatility rate increased by 17.23%, as shares sank -23.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +68.54% upper at present.
During the last 5 trading sessions, SPRC fell by -24.09%, which changed the moving average for the period of 200-days by -69.48% in comparison to the 20-day moving average, which settled at $0.6474. In addition, SciSparc Ltd saw 11.89% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for SPRC
Current profitability levels for the company are sitting at:
- -2.01 for the present operating margin
- 0.76 for the gross margin
The net margin for SciSparc Ltd stands at -1.78. The total capital return value is set at -0.6. Equity return is now at value -103.20, with -55.80 for asset returns.
Based on SciSparc Ltd (SPRC), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -77.46.
Currently, EBITDA for the company is -5.31 million with net debt to EBITDA at 0.38. When we switch over and look at the enterprise to sales, we see a ratio of 0.75. The receivables turnover for the company is 10.03for trailing twelve months and the total asset turnover is 0.26. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.86.
Conclusion
In conclusion, SciSparc Ltd (SPRC) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
